Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01071993 · ClinicalTrials.gov registry record · NA
Efficacy of Statins In Prevention of CIN
A NA study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01071993 is a NA study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 21 participants.
The verdict
NCT01071993, a NA study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To determine if statin therapy plus intravenous normal saline, in patients with chronic renal insufficiency undergoing angiography, is superior to placebo plus intravenous normal saline therapy in the prevention of CIN.
Interventions
- DRUG placebo
- DRUG atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01071993
The ClinicalTrials.gov registry entry for NCT01071993 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01071993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01071993 about?
NCT01071993 is a clinical study titled "Efficacy of Statins In Prevention of CIN". To determine if statin therapy plus intravenous normal saline, in patients with chronic renal insufficiency undergoing angiography, is superior to placebo plus intravenous normal saline therapy in the prevention of CIN.
What is the current status of trial NCT01071993?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2010-03. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01071993?
The interventions under investigation include: placebo (DRUG), atorvastatin (DRUG).
Who is sponsoring clinical trial NCT01071993?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.